Bradycardia Caused by interaction of Venlafaxine and Cyclosporine: A case report

Background: Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) are prescribed widely for the treatment of depression, anxiety disorders and other psychiatric disorders. Although antidepressants are considered as a safety drug category but unexpec...

Full description

Bibliographic Details
Main Authors: Marzieh Azizi, Forouzan Elyasi, fatemeh Niksolat Roodposhti
Format: Article
Language:English
Published: Babol University of Medical Sciences 2019-09-01
Series:Caspian Journal of Internal Medicine
Subjects:
Online Access:http://caspjim.com/article-1-1321-en.html
_version_ 1828445404585263104
author Marzieh Azizi
Forouzan Elyasi
fatemeh Niksolat Roodposhti
author_facet Marzieh Azizi
Forouzan Elyasi
fatemeh Niksolat Roodposhti
author_sort Marzieh Azizi
collection DOAJ
description Background: Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) are prescribed widely for the treatment of depression, anxiety disorders and other psychiatric disorders. Although antidepressants are considered as a safety drug category but unexpected cardiovascular events have been reported as the most serious complications. The aim of this study was to introduce a case presentation on bradycardia due to the drug interference of venlafaxine and cyclosporine. Case presentation: The patient was a 38-year old woman diagnosed with systemic lupus erythematosus 5 years ago, who was admitted to a general educational hospital in northern Iran due to intensified rheumatologic symptoms and complaining about abdominal pain. Cyclosporine tab were administered to the patient, 50 mg twice daily. Two weeks after the administration of cyclosporine, the level of blood cyclosporine was checked. The patient became bradycardic after starting a single dose of venlafaxine (heart rate 52 ppm). Cardiac assessment showed no reason for bradycardia and it subsided after a drop of venlafaxine. Conclusion: As a result of the potential adverse drug interactions between cyclosporine and antidepressants such as venlafaxine, physicians should be aware of the possibility of bradycardia in the simultaneous prescription of these drugs in cases.
first_indexed 2024-12-10T21:57:37Z
format Article
id doaj.art-945cbaef24384929950b1d629dd153a1
institution Directory Open Access Journal
issn 2008-6164
2008-6172
language English
last_indexed 2024-12-10T21:57:37Z
publishDate 2019-09-01
publisher Babol University of Medical Sciences
record_format Article
series Caspian Journal of Internal Medicine
spelling doaj.art-945cbaef24384929950b1d629dd153a12022-12-22T01:32:00ZengBabol University of Medical SciencesCaspian Journal of Internal Medicine2008-61642008-61722019-09-01104463467Bradycardia Caused by interaction of Venlafaxine and Cyclosporine: A case reportMarzieh Azizi0Forouzan Elyasi1fatemeh Niksolat Roodposhti2 Sexual and Reproductive Health Research Center, Nasibeh Nursing and Midwifery Faculty, Mazandaran University of Medical Sciences, Sari, Iran Department of Psychiatry, Psychiatry and Behavioral Sciences Research Center and addiction Institute, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran Department of Internal Medicine, Orthopedic Research Center, Mazandaran University of Medical Sciences, Sari, Iran Background: Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) are prescribed widely for the treatment of depression, anxiety disorders and other psychiatric disorders. Although antidepressants are considered as a safety drug category but unexpected cardiovascular events have been reported as the most serious complications. The aim of this study was to introduce a case presentation on bradycardia due to the drug interference of venlafaxine and cyclosporine. Case presentation: The patient was a 38-year old woman diagnosed with systemic lupus erythematosus 5 years ago, who was admitted to a general educational hospital in northern Iran due to intensified rheumatologic symptoms and complaining about abdominal pain. Cyclosporine tab were administered to the patient, 50 mg twice daily. Two weeks after the administration of cyclosporine, the level of blood cyclosporine was checked. The patient became bradycardic after starting a single dose of venlafaxine (heart rate 52 ppm). Cardiac assessment showed no reason for bradycardia and it subsided after a drop of venlafaxine. Conclusion: As a result of the potential adverse drug interactions between cyclosporine and antidepressants such as venlafaxine, physicians should be aware of the possibility of bradycardia in the simultaneous prescription of these drugs in cases.http://caspjim.com/article-1-1321-en.htmlbradycardiavenlafaxinecyclosporineserotonin-norepinephrine reuptake inhibitorsselective serotonin reuptake inhibitors.
spellingShingle Marzieh Azizi
Forouzan Elyasi
fatemeh Niksolat Roodposhti
Bradycardia Caused by interaction of Venlafaxine and Cyclosporine: A case report
Caspian Journal of Internal Medicine
bradycardia
venlafaxine
cyclosporine
serotonin-norepinephrine reuptake inhibitors
selective serotonin reuptake inhibitors.
title Bradycardia Caused by interaction of Venlafaxine and Cyclosporine: A case report
title_full Bradycardia Caused by interaction of Venlafaxine and Cyclosporine: A case report
title_fullStr Bradycardia Caused by interaction of Venlafaxine and Cyclosporine: A case report
title_full_unstemmed Bradycardia Caused by interaction of Venlafaxine and Cyclosporine: A case report
title_short Bradycardia Caused by interaction of Venlafaxine and Cyclosporine: A case report
title_sort bradycardia caused by interaction of venlafaxine and cyclosporine a case report
topic bradycardia
venlafaxine
cyclosporine
serotonin-norepinephrine reuptake inhibitors
selective serotonin reuptake inhibitors.
url http://caspjim.com/article-1-1321-en.html
work_keys_str_mv AT marziehazizi bradycardiacausedbyinteractionofvenlafaxineandcyclosporineacasereport
AT forouzanelyasi bradycardiacausedbyinteractionofvenlafaxineandcyclosporineacasereport
AT fatemehniksolatroodposhti bradycardiacausedbyinteractionofvenlafaxineandcyclosporineacasereport